Firms

Advent Life Sciences

Advent Life Sciences

adventls.com

Advent Life Sciences is a London-based life-sciences venture capital investor and company builder, managed by Advent Life Sciences LLP. It backs early innovation, often from seed or SeriesA, and works with founders on scientific and clinical development, operations, team building and financing. Its portfolio spans biotechnology, therapeutics, gene therapy, diagnostics and medical devices, including neuroscience-related companies Pheno Therapeutics, AviadoBio and Nalu Medical. The firm’s published team combines investment partners, scientific and clinical advisers, operating partners and finance and support staff.

Founded
—
Type
Venture capital

Funds3

  • Advent Life Sciences Fund III—

    Third dedicated life-sciences fund announced closed alongside the Advent-Harrington Impact Fund on February18,2021. The manager disclosed USD215 million combined commitments across both funds; no individual split was published in the reviewed release. New limited partners included British Patient Capital.

  • Advent-Harrington Impact Fund—

    Impact investment fund raised in collaboration with Harrington Discovery Institute to translate academic drug discoveries into treatments. Announced closed with Advent Life Sciences Fund III on February18,2021; USD215 million was combined commitments across the two vehicles, not this fund’s individually disclosed size.

  • Advent Life Sciences Fund II£145M

    Life-sciences venture capital fund closed at GBP145.5 million to seed and build companies in the UK, Europe and US. The announced USD235 million equivalent is the same fund, not additional capital.

Team

Operations and support

Alain HuriezVenture Partner
Alan E. WaltsVenture Partner
Andrea BeesleyTeam Assistant
Bonita ThearaExecutive Assistant
Dominic SchmidtDominic SchmidtGeneral Partner
Don DrakemanVenture Partner
Edward DavidAssociate
Fraser MurrayFraser MurrayHead of Scientific Evaluation
Gail JermynInvestor Relations Partner
Gwen O’DriscollAnalyst
Ian J. NicholsonOperating Partner
John RexOperating Partner
Jon MooreOperating Partner
Kaasim MahmoodGeneral Partner
Katrine BosleyVenture Partner
Majid KazmiClinical Advisor
Raj ParekhGeneral Partner
Rowena PatelFinancial Director
Roy LobbVenture Partner
Satish JindalGeneral Partner
Shahzad MalikGeneral Partner
Steve PawseyGrowth Partner
Tom WigmoreFinancial Accountant
Victoria SmithFinancial Controller
William EveringhamAccounts Assistant

Co-investing

LifeArc Ventures
Dementia Discovery Fund
F-Prime Capital
Johnson & Johnson Innovation – JJDC
Aperture Venture Partners

Investments